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Objectives. This paper sought to conduct a meta-analysis of the effectiveness and
durability of cognitive analytic therapy (CAT) and assess the acceptability of CAT in terms
of dropout rates.
Design. Systematic review and meta-analysis.
Methods. PROSPERO registration: CRD42018086009. Searches identified CAT
treatment outcome studies eligible to be narratively synthesized. Pre–post/post-
follow-up effect sizes (ESs) were extracted and synthesized in a random-effects meta-
analysis. Variations in effect sizeswere explored usingmoderator analyses. Dropout rates
were extracted. Secondary analyses synthesized between-group ES from trials of CAT.
Results. Twenty-five studies providing pre–post CAT treatment outcomes were
aggregated across three outcome comparisons of functioning, depression, and interper-
sonal problems. CAT produced large pre–post improvements in global functioning
(ES = 0.86; 95% CI 0.71–1.01, N = 628), moderate-to-large improvements in interper-
sonal problems (ES = 0.74, 95% CI 0.51–0.97, N = 460), and large reductions in
depression symptoms (ES = 1.05, 95% CI 0.80–1.29, N = 586). All these effects were
maintained or improved upon at follow-up. Limited moderators of CAT treatment effect
were identified. CAT demonstrated small–moderate, significant post-treatment benefits
compared to comparators in nine clinical trials (ES = 0.36–0.53; N = 352). The average
dropout rate for CAT was 16% (range 0–33%).
Conclusions. Patients with a range of presenting problems appear to experience
durable improvements in their difficulties after undergoing CAT. Recommendations are
provided to guide the further progression of the CAT outcome evidence base.
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Practitioner points
 Large pre–post reductions in global functioning and depression outcomes and moderate–large
reductions in interpersonal problems are evident after CAT.
 The effects of CAT appear durable, and interpersonal functioning significantly improves over follow-up
time.
 CAT produces small–moderate benefits compared to trial comparators.
 CAT appears to be an engaging psychotherapy that maintains patients in treatment.
Access to and the provision of psychological therapies in public services is underpinned
by the philosophy of ‘evidence-based’ practice (EBP; McHugh & Barlow, 2012) to enable
patients to be treated with empirically supported psychotherapies (Tolin, McKay,
Forman, Klonsky, & Thombs, 2015). The ‘hourglass model’ (Salkovskis, 1995) defines the
three-stage cyclical process enabling EBP: (1) completion of initial practice-based
evidence (PBE) studies, (2) generation of methodologically robust clinical efficacy trials,
and (3) implementation of evidenced-based psychotherapies in services, with associated
audit and evaluation. Barkham, Stiles, Lambert, and Mellor-Clark (2010) advocated
equipoise in relation to EBP and PBE, to encourage a balanced critique of the evidence
base for any psychotherapy. Public service commissioning demands good evidencewhen
deciding on funding, and so, cognitive analytic therapy (CAT) is required to demonstrate
that it is an acceptable, safe, and effective intervention (Marriott & Kellett, 2009). A
discrepancybetween the large amount of PBE versus small amount EBP evidence has been
previously highlighted for CAT (Calvert & Kellett, 2014). This places CAT in a vulnerable
position of being widely practised, but currently with a lack of confidence and clarity
around the acceptability, efficacy, and effectiveness of the approach (Margison et al.,
2000).
In response, Ryle, Kellett, Hepple and Calvert (2014) completed an initial quantitative
synthesis of CAT evidence via a meta-analysis of eleven pre–post study effect sizes (ESs)
and demonstratedmoderate-to-large effects. Therewere, however, five critical limitations
that the current review sought to address. First, it was unclear why and which measures
were used, thus limiting the conclusions able to be drawn about specific effects
(Kızılırmak, €Ozdemir, & €Ongen, 2015). Analysing the impact of CAT on specific outcomes
would provide insight into the types of change CAT can produce. Second, aggregated
follow-up comparisons nor moderators of CAT treatment effect were evaluated.
Therefore, understanding the durability of CAT and also the features of the model which
contribute to more beneficial effects was indicated. Third, no within-group correlations
were performed when calculating the pre–post ES – hence, completing correlations
would improve the reliability of the ES produced. Fourth, no assessment of study quality,
nor any quantitative analysis on the impact study quality on CAT treatment effects was
completed. As study quality can inflate ES estimates (Cuijpers, Donker, Weissman, Ravitz,
& Cristea, 2016), this study also sought to quality assess the studies and complete a
moderator analysis of the role of studyquality. Fifth, theuseof pre–post ESwithout control
group comparisons (e.g., passive and active controls in clinical trials) meant it was not
possible to specifically attribute change to CAT, because treatment effects could not be
separated from effects of time. The number of randomised controlled trials (RCTs) of CAT
conducted since theRyle et al. (2014) review, althoughnot sufficient for a comprehensive
disorder-specific synthesis, did offer the opportunity to conduct a preliminary evaluation
of CAT treatment effects relative to control groups in the RCT evidence base.
To summarize, the main aims of the present review were to provide a
contemporary quantitative synthesis of the CAT evidence base by producing a well-
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conducted meta-analysis of pre–post and follow-up CAT outcomes, moderators of ES
observed, and produce an initial evaluation of the efficacy of CAT. The study also
sought to differentiate the effect of CAT on different clinical outcomes: global
functioning, interpersonal problems, and depression. Due to limitations of uncon-
trolled pre–post ES, conclusions about the effectiveness of CAT throughout this
review in the PBE studies should be considered in the context that patients
undergoing CAT have experienced improvements in their difficulties, but the
improvements cannot be specifically attributed to CAT. As such, a secondary aim
was to provide an initial estimate of between-groups treatment effects on overall
outcomes when CAT is compared to any comparator from the available controlled
trials. Finally, CAT has been presented previously as an engaging psychotherapy that
creates low dropout rates across diagnoses (Calvert & Kellett, 2014), and so, this study
sought to assess the average dropout rate for CAT.
Method
The review was preregistered on PROSPERO (CRD42018086009) and is reported
according to PRISMA guidelines (Moher et al., 2015).
Study selection
Electronic searches of four databases (PsycINFO,MEDLINE,CINAHL, andWebof Science)
were conducted using the search term cognitive analytic (allowing for wildcard
variations modified for each database), replicating the previous CAT review (Calvert &
Kellett, 2014). No search limiters were applied, with the searches identifying studies of
CAT treatment outcome published up until 2019 (final search was performed on 23
August 2019). Reference lists of identified studies and the list of published CAT studies on
the Association of Cognitive Analytic Therapy (ACAT) website were cross-referenced to
identify any additional studies not identified by the database search. Finally, key authors
were emailed to enquire about further studies of CAT and authors’ publication lists were
checked. After duplicates were removed, the primary reviewer screened titles and
abstracts and reviewed the identified full texts against the inclusion and exclusion criteria.
An independent reviewer (trainee clinical psychologist) screened 25% of the full-text
articles and checked 25% of the included studies to ensure they met eligibility criteria,
with discrepancies resolved through discussion (rater agreement = 81%). Overall,
consensus on study eligibility queries was achieved via discussion amongst all members
of the review team.
Eligibility criteria
Articles were eligible for inclusion if they were a treatment outcome study that reported
pre- and post-treatment scores on a validated outcome measure (i.e., means and standard
deviations [SDs]) for adults (mean sample age 16+) treated with CAT for any psychiatric
diagnosis or problem related to psychological factors. Studies were included if they used
either a RCT, a non-randomised controlled trial, an uncontrolled (pre–post) design, or a
case-series design. Both group and individual delivery of CAT were eligible, with no
restriction on treatment setting. Studies that combined CAT with another treatment
modality (e.g., CAT combined with CBT) were excluded, as were the CAT consultancy
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studies and all the single-case experimental design studies. Included studieswere required
to be available in English language and be published or have undertaken a peer-review
process to ensure a minimum standard of study quality and replicable search procedures.
Unpublished dissertations and conference papers were excluded. For inclusion in the
primary quantitative synthesis, pre–post treatment outcomes were required to have been
assessed using a validatedmeasure of global functioning, interpersonal difficulties, and/or
depression. Ameasurewas considered validated if adequate psychometric properties had
been demonstrated in a published study. Studies were excluded if they did not provide
sufficient information to calculate ES (i.e., means and SD). For inclusion in the secondary
between-groups synthesis, studies were required to have used a RCT design and assessed
post-treatment between-groups outcomes on one of the specified outcome categories or
any other psychiatric outcome measure for CAT versus any comparator condition.
Outcomes
Primary analyses
The three outcomes of interest were self-report measures of global functioning (e.g.,
Symptom Checklist-Revised-90 [SCL-R-90], Clinical Outcomes in Routine Evaluation-
Outcome Measure [CORE-OM], Brief Symptom Inventory [BSI]), interpersonal difficul-
ties (e.g., Inventory of Interpersonal Difficulties [IIP], Persons Related to Others
Questionnaire-2 [PROQ-2]), and depression (e.g., Beck Depression Inventory [BDI/BDI-
II], Hospital Anxiety and Depression Scale [HADS-D], Patient Health Questionnaire-9
[PHQ-9]). Originally, additional outcomes relating to anxiety measures and remission
rates were included in the protocol; however, insufficient eligible studies assessed these
outcomes, so the analyses were not performed. To ensure each study contributed only
one ES per outcome, the most frequently used measure was selected when multiple
measures of one outcomewere reported. Dropout rateswere also evaluated as a proxy for
CAT treatment acceptability. Dropout was determined as percentage of patients who
completed treatment according to the definition used in the original study.
Secondary analyses
Due to limited comparability between types of outcomes assessed in the eligible RCTs,
between-groups comparisons assessed overall treatment outcome as measured by any of
the outcome measures from the primary analysis or a disorder-specific outcome measure
(if one of the primary outcomes measures was not assessed) rather than across each
outcome separately (as specified in the original protocol). ES from individual studies that
assessedmore than one of the three primary outcomeswas first aggregated in aminimeta-
analysis to capture the aggregated treatment outcome and ensure only one ES per study
was included.
Quality assessment
The Downs and Black (1998) 27-item quality checklist was used to assess methodological
quality as it incorporates randomized and non-randomized study designs. This tool
assesses five aspects of methodological quality – reporting (10 items); internal validity –
confounding (6 items); internal validity – bias (7 items); external validity (3 items); and
power (1 item). Due to reported difficulties in applying the item relating to power, this
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itemwasmodified to a yes/no response to indicatewhether the study had adequate power
(0.8) to detect a pre–post moderate ES (0.6; based on lower bound confidence interval of
previous CAT meta-analysed aggregated ES) at a < .05 (O’Connor et al., 2015). Studies
were therefore assessed on a scale of 0–28 (higher scores indicated higher quality) and
categorized according to the following quality thresholds; poor (<14), fair (14–18), good
(19–23), and excellent (24–28). The primary reviewer assessed all included studies, with
30% double-rated by an independent rater (trainee clinical psychologist). Inter-rater
agreementwas assessedwith Cohen’s kappa statistic (k), interpreted as .21–40 indicating
fair agreement, .41–.60 as moderate agreement, .61–.80 as substantial agreement, and
.81–1.0 as almost perfect agreement (Cohen, 1960; Landis & Koch, 1977). There was
substantial agreement between the raters (k = 0.77). Any discrepancies between raters
were discussed and a consensus reached to produce an agreed quality score for each
study.
Data extraction
An a priori extraction tool was designed to code data on the following criteria: (1)
methodological characteristics (study design, study quality, assessment of therapist’s
competence using CCAT [yes/no], mean CCAT score, and indication of therapist
competence [CCAT> 20 competent CAT/CCAT < 20 incompetent CAT], (2) inter-
vention characteristics (number of sessions, format [group/individual], treatment
setting, and therapist qualification [CAT qualified/trainee], patient characteristics
(age, gender [% male], and specified difficulties), and outcomes (pre- and post-
treatment means, SDs, and dropout rates). Data on whether studies assessed adverse
effects (hospital admissions, reliable deterioration rates) during CAT were also
extracted. Where data were not reported, the information was requested from authors
by email.
Effect sizes
Pre–post effect sizes
For the primary analyses, pre–post ESwas calculated for global functioning, interpersonal
difficulties, and depression outcomes. ES was calculated by subtracting the mean post-
treatment score from the mean pre-treatment score and dividing by the pre-treatment
standard deviation (SD). To account for the violation of independence, calculations for
pre–post ES require an estimate of the correlation betweenpre- andpost-scores (r).Where
pre–post correlations were reported, the actual value of rwas used to calculate individual
study ES. In the absence of a reported pre–post correlation, an imputed value of 0.6 was
used based on the median within-group correlation extracted from 811 measures of pre–
post clinical trial arms (Balk et al., 2012) and sensitivity analyses were conducted to
evaluate the effect of different imputed r values (see moderator and sensitivity analyses
section). ES was converted to Hedges g using the J-correction to account for small study
sample biases (Hedges &Olkin, 1985). If a study had used a RCT or controlled trial design,
pre–post ES was calculated for the CAT treatment arm only. Positive ES indicated
symptom reductions after treatment (negative ES indicated symptom deterioration) and
was interpreted as 0.2 indicating a small effect, 0.5 indicating a moderate effect, and 0.8
indicating a large effect size (Cohen, 1992).
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Between-groups effect sizes
For the secondary analyses, pre-/post-control group effect sizes were calculated for
included studies that had used a RCT design to calculate the effect of CAT versus
comparator groups. ES was calculated by subtracting the mean pre–post change of the
comparison group from the mean pre–post change in the CAT group and dividing by the
pooled pre-treatment SD to account for pre-treatment group differences (Morris, 2008).
Where there was a follow-up assessment, post-treatment to follow-up control group ES
was calculated using the same procedure. All ESs were adjusted using the small study J-
correction (Hedges & Olkin, 1985). Positive ES indicated a treatment effect in favour of
CAT.
Data synthesis
Effect sizes were synthesized via a random-effects meta-analysis with inverse variance
weighting (based on the DerSimonian & Laird, 1986 estimator) using Meta-Essentials
workbooks (Suurmond, van Rhee, & Hak, 2017). Overall, pooled treatment estimates,
95% confidence intervals (CI), and prediction intervals (PI) were produced using the
inverse of the variance to weight effect estimates. Between-study heterogeneity was
assessed using the I2 statistic to indicate thepercentage of variation and the accompanying
Q statistic to assess significance. Study heterogeneity was grouped into low (25%),
moderate (50%), and high (75%) thresholds (Higgins, Thompson, Deeks, &Altman, 2003).
Moderator and sensitivity analyses
In the primary analyses, the anticipated between-study heterogeneity was explored using
pre-specified subgroup and meta-regression analyses. Subgroup analysis was used to
explore four categorical variables: study type [PBE/RCT], therapist experience [CAT
qualified/not qualified], format [1:1/group], and diagnosis [personality disorder/other].
Due to the range of presentations treated, diagnosis classifications were collapsed into
two groups: (1) cases (or over half of included cases) presenting with a personality
disorder and (2) all other diagnoses. Meta-regressionwas used to explore four continuous
variables: study quality, gender [% male], mean age, and treatment duration [number of
sessions]. To account for multiple testing, the alpha threshold for significance was
adjusted to p < 0.0125 (a = .05/4) for between-subgroup differences and meta-regres-
sion beta-coefficients, respectively. A minimum of 10 studies were required to perform
moderator analyses (Cochrane Collaboration, 2011).
Due to typically low rates of reporting for pre–post r values, sensitivity analyses were
employed to investigate the effect of imputing different values for r in ES calculations on
the overall estimated CAT treatment effect (Borenstein, 2009). Four separate overall CAT
treatment effectswere aggregated using study ES calculatedwith the value of r imputed as
0.0, 0.25, 0.5, and 0.75, respectively (Balk et al., 2012).Where possible, ES for studies that
reported a true value for rwas also aggregated and compared to the aggregated imputed ES
(using r = 0.6 from themain analyses) for the same studies to assess the potential bias that
might be present in the findings in the absence of knowing the true r values.
Publication bias
Publication bias was assessed via three approaches: (1) Funnel plots of study ES plotted
against standard errors (SE)were visually inspected for asymmetry (indication of reporting
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biases in the included studies); (2) Egger’s regression was used to statistically test for the
presence of publication bias (Egger, Smith, Schneider, &Minder, 1997); and (3) ‘Trim and
Fill’ imputation was conducted to estimate treatment effects adjusted for publication bias
(Duval & Tweedie, 2000).
Results
Study selection
The search strategy produced a combined total of 28 CAT outcome articles (Figure 1).
After the removal of duplicates, a total of 576 articles were screened with 100 identified
for full-text review. Thirty articles were initially deemed eligible for inclusion, although
two studieswere subsequently excluded, as theywere reports on the samedata of another
included study. This left k = 28 articles for qualitative synthesis, with k = 25 studies
eligible for the primary pre–post quantitative synthesis and k = 9 RCTs for the secondary
between-groups quantitative synthesis.
Study characteristics
Characteristics of the included studies are presented in Table 1. Of the 28 included
studies, k = 10 (36%) were RCTs and the remaining k = 18 (64%) were PBE studies (pre–
post design k = 10; case series k = 8). Mean study quality was 12.68 (SD = 4.50;
maximumscore 28), ranging between 5 and 21 (see supplementarymaterials for full study
quality ratings). Overall study quality was poor, with only 11 studies classified as fair and
three as good. The RCTs of CAT generated higher ratings of methodological quality
(mean = 16.6, SD = 3.75), than the PBE studies (mean = 10.22, SD = 3.44). Studyquality
by sub-domain highlighted that studies scored highest in terms of methodological
reporting (with the exception of reporting adverse events). Study quality was lowest for
internal validity related to confounding in selection biases, particularly in terms of lack of
randomization and lack of adequate adjustment for confounding in the analyses. In terms
of power, less than half (k = 12) of the studies were sufficiently powered to detect a
moderate pre–post effect.
All studies bar one were conducted in public health services. CAT was typically
delivered individually (k = 26; 93%) or occasionally in groups (k = 2; 7%). Treatment
duration ranged from 5 to 30 sessions. CAT was employed in the standard eight-session
(k = 2; 7%), 16-session (k = 10; 35%), or 24-session (k = 8; 28%) versions, with k = 5
(18%) studies using a combination of treatment versions. A six-session (k = 1), 12-session
(k = 1), and 20-session (k = 1) versions were used in the remaining studies (k = 1 study
did not report treatment duration; total studies exceed number of included studies as one
study included separate 16- and 24-session CAT groups). In k = 13 studies, therapists
were qualified with the remaining k = 15 studies either comprising of trainee CAT
therapists or therapists without accredited as a CAT practitioner. Just k = 5 studies (18%)
reported competency ratings, with all reporting mean Competence in Cognitive Analytic
Therapy (CCAT) scores exceeding the competence cut-off (>20; Bennett & Parry, 2004).
The age of patients ranged between 16 and 49 years. Presenting problems include
mixed diagnoses (k = 8), personality disorders (PD; k = 5), complex trauma (k = 3),
anxiety/panic disorder (k = 2), anorexia nervosa (k = 2), depression (k = 1), obsessive–
compulsive disorder (OCD; k = 1), bipolar disorder (k = 1), psychosis (k = 1), morbid
jealousy (k = 1), seriousmental disorders (k = 1), chronic pain (k = 1), andpoor diabetes
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management (k = 1). Twenty studies reported follow-up data, with follow-ups ranging
between 1 and 24 months (mean = 7.5 months). Dropout rates ranged between 0 and
39% (mean = 15%). Adverse events were reported in seven studies (k = 2 studies
reported incidents of hospital admissions; k = 5 had no serious adverse events). Rates of
reliable deterioration after CAT were available in k = 16 studies; k = 11 studies reported
no reliable deterioration,while k = 5 studies reported incidences of deterioration ranging
between 6 and 20% (mean = 11.4%).
Primary meta-analysis of pre–post CAT treatment effects
Meta-analytic comparisons were conducted on pre–post treatment and from post-
treatment to follow-up global functioning, interpersonal problems, and depression
Articles excluded, with reasons (n = 3)
Measures not relevant (n = 3)
Studies included in qualitative synthesis 
(n = 28)
Records identified through 
database searching
(n = 735)
Records identified through 
ACAT website
(n = 104)
Total records identified
(n = 846)
Records screened
(n = 576)
Full-text articles assessed for eligibility 
(n= 100)
Full-text articles excluded, with reasons 
(n = 70)
Not treatment outcome study (n = 24)
Unpublished/conferencepaper (n = 12)
CAT combined with other approach (n = 2)
Used CAT consultancy model (n = 2)
Case studies (n = 20)
Insufficient data to calculate effect size  (n = 2)
Full-text not available (n = 7)
Full-text not in English language (n = 1)
*See supplementary materials for excluded study 
table
Eligible studies included in primary pre-
post quantitative synthesis (meta-
analysis) 
(n = 25)
I d
e
n
ti
fi
ca
ti
o
n
S
cr
e
e
n
in
g
E
lig
ib
i li
t y
In
c l
u
d
e
d
Paper excluded as data from same trial 
published twice (n = 2) 
Papers initially considered for the review
(n = 30)
Duplicate records removed
(n = 270)
Records identified through 
other sources 
(n = 7)
Records excluded
(n = 476)
Eligible studies included in secondary 
between-groups quantitative synthesis 
(meta-analysis) 
(n = 9)
Articles excluded, with reasons (n = 19)
Not an RCT design (n = 18)
Comparator a CAT deconstruction (n = 1)
Figure 1. PRISMA flow chart of study selection.
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Table 1. Characteristics of included studies
Study First Author
(Year)
Study type
(design)
Treatment
setting
(presenting
problem) N
Mean age (SD)
[range]
Sex (%
male)
Therapist CAT
qualified
(mean CCAT
score)
Treatment
duration
(format) Measures
Follow-up
duration
(months)
Dropout
rate%
Adverse
events (% RD)
Quality
score
[1] Brockman et al.
(1987)b
RCT Hospital clinic
(mixed)
30 NR NR No (N/A) 12 (1:1) GHQ
BDI
8–22a 12% NR (NR) 7 (Poor)
[2] Clarke and
Llewelyn (1994)
PBE (case
series)
NHS clinic
(complex
trauma)
7 27 (10.05) [19–48] 0% Yes (N/A) 16 (1:1) SCL-90-R
BDI
3 14% NR (0%) 7 (Poor)
[3] Evans and Parry
(1996)
PBE (case
series)
Not specified
(mixed)
4 32 (8.12) [24–42] 0% Yes (N/A) 13–20 (1:1) SCL-90-R None 0% NR (0%) 5 (Poor)
[4] Dunn et al.
(1997)
PBE (pre–
post)
Hospital clinic
(mixed)
164 NR 42% No (N/A) 16 (1:1) SCL-90-RIIP
BDI
None 18% NR (NR) 11 (Poor)
[5] Fosbury et al.
(1997)b
RCT Diabetes clinic
(poor diabetes
control)
10 30.5 (10.6) [18–55] 30% Not specified (N/A) 16 (1:1) IIP 3 & 9 33% NR (NR) 17 (Fair)
[6] Clarke and
Pearson (2000)
PBE (case
series)
Outpatient
(complex
trauma)
4 32.50 (13.96) [22–
53]
100% Yes (N/A) 16 (1:1) SCL-90-R
BDI
None 0% NR (NR) 6 (Poor)
[7] Ryle and
Golynkina (2000)
PBE (pre–
post)
Hospital clinic
(BPD)
27 34.3 (7.5) 41% Majority no (N/A) 24 (1:1) SCL-90-R
IIP
BDI
18 13% 2 hospital
admissions
(0%)
11 (Poor)
[8] Wildgoose et al.
(2001)
PBE (case
series)
NHS clinic (BPD) 5 39.40 (7.13) [30–
47]
40% Yes (N/A) 16 (1:1) SCL-90-R
IIP
9 0% NR (20%) 6 (Poor)
[9] Birtchnell et al.
(2004)
PBE (pre–
post)
Psychotherapy
service (mixed)
31 39.0 (10.1) [22–61] 24% No (N/A) 16 (1:1) CORE
PROQ-2
3 22.5% NR (NR) 9 (Poor)
[10] Chanen et al.
(2008)b
RCT Youth clinic
(BPD)
41 16.3 (0.8) 17% Yes (N/A) 24 (1:1) SOFAS 12 & 24 29.3% No adverse
effects (NR)
16 (Fair)
[11] Marriott and
Kellett (2009)
PBE (pre–
post)
Psychotherapy
service (mixed)
ST: 38
MT: 27
NR ST:42%
MT:26%
Yes (N/A) ST – 16
MT 24 (1:1)
BSI
IIP
BDI-II
None NR NR (NR) 12 (Poor)
[12] Tzouramanis
et al. (2010)
PBE (pre–
post)
Community
mental health
centre (panic
disorder)
128 33.4 (8.9) 21% NR (N/A) NR (1:1) BDI 12 16% NR (NR) 6 (Poor)
[13] Clarke et al.
(2013)b
RCT Specialist PD
clinic
(personality
disorder)
38 36 (9.5) [19-59] 28% Yes (22) 24 (1:1) CORE
IIP
18 20% No diff in
hospital
admissions
(9-11%)
16 (Fair)
[14] Kellett et al.
(2013)
PBE (pre–
post)
NHS clinics
(BPD)
17 29.99 (8.77) 18% Yes (34.35) 24 (1:1) CORE 6 11% NR (6%) 15 (Fair)
Continued
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Table 1. (Continued)
Study First Author
(Year)
Study type
(design)
Treatment
setting
(presenting
problem) N
Mean age (SD)
[range]
Sex (%
male)
Therapist CAT
qualified
(mean CCAT
score)
Treatment
duration
(format) Measures
Follow-up
duration
(months)
Dropout
rate%
Adverse
events (% RD)
Quality
score
[15] Calvert et al.
(2015)
PBE (pre–
post)
Psychotherapy
service
(complex
trauma)
157 34.65 (10.67) [18–
64]
0% No (N/A) 24 (group) BSI
IIP
HADS-d
None 22% NR (7%) 14 (Fair)
[16] Darongkamas
et al. (2017)
PBE (pre–
post)
NHS clinic
(mixed)
47 41 [16–69] 35% No (NA) 8, 16 & 24
[mode = 16]
(1:1)
CORE
IIP
None NR NR (0%) 9 (Poor)
[17] Evans et al.
(2017)b
RCT Psychotherapy
service
(bipolar
disorder)
9 48.33 (9.84) 22% Yes (34.16) 24 (1:1) CORE
BDI-II
6 &12 11% No adverse
events (0%)
18 (Fair)
[18] Meadows and
Kellett (2017)
PBE (pre–
post)
Primary care
service
(anxiety)
11 37 (10.7) [24–57] 41% No (N/A) 6 (1:1) PHQ-9 1 9% NR (0%) 13 (Poor)
[19] Kellett et al.
(2018)
RCT Primary care
service
(depression)
CAT: 52
CAT-NR:
43
43.3 (11.8) 39.3
(11.1)
25%
22%
No (25) 8 (1:1) PHQ-9 2 19%
14%
No adverse
events (0%)
19 (Good)
[20] Taylor et al.
(2018)
PBE (case
series)
NHS clinics
(psychosis)
7 26.71 (6.40) [19–
34]
57% No (29) 5–30 (1:1) SOFAS 2 14% No adverse
events (14%)
15 (Fair)
[21] Curling et al.
(2018)
PBE (case
series)
NHS clinic
(obsessive
morbid
jealousy)
3 49.3 (11.72) [36–
58]
33% Yes (N/A) 16–24 (1:1) BSI
IIP
BDI-II
4 0% NR (0%) 14 (Fair)
[22] Tyrer and
Masterson (2019)
PBE (case
series)
NHS clinic
(mixed – all
had low mood)
6 41.67 (18.76) [26–
73]
17% Yes (N/A) 16 (1:1) CORE 3 0% NR (0%) 8 (Poor)
[23] Baronian and
Leggett (2019)
PBE (pre–
post)
Pain management
service
(chronic pain)
53 48.1 (12.52) 25% Yes (N/A) 8 (1:1) CORE None 5.2% NR (0%) 14 (Fair)
[24] Kellett et al.
(2019a)b
RCT High secure
hospital
(serious
mental
disorder)
10 38.70 (9.38) [18–
65]
100% No (N/A) 16 (group) PROQ-2 2 10% NR 21 (Good)
[25] Kellett et al.
(2019b)
PBE (case
series)
Private sector
CAT clinic
(mixed anx/
dep or PD)
7 NR NR Yes (N/A) 16 or 24 (1:1) CORE None 30% NR (0%) 9 (Poor)
Continued
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Table 1. (Continued)
Study First Author
(Year)
Study type
(design)
Treatment
setting
(presenting
problem) N
Mean age (SD)
[range]
Sex (%
male)
Therapist CAT
qualified
(mean CCAT
score)
Treatment
duration
(format) Measures
Follow-up
duration
(months)
Dropout
rate%
Adverse
events (% RD)
Quality
score
Studies included in
secondary
quantitative
between-groups
synthesis only
[26] Treasure et al.
(1995)b
RCT Outpatient eating
disorder clinic
(anorexia
nervosa)
14 NR NR NR (N/A) 20 (1:1) Morgan &
Russell scalec
12 29% NR (NR) 19 (Good)
[27] Dare et al.
(2001)b
RCT Outpatient eating
disorder clinic
(anorexia
nervosa)
21 27.2 (7.6) 0% NR (N/A) 24 (1:1) Morgan &
Russell scalec
12 38% 2 hospital
admissions
(NR)
17 (Fair)
[28] Ameri et al.
(2017)b
RCT Psychiatric
centre (OCD)
12 37.78 (5.38) [31–
44]
50% No (N/A) 16 (1:1) Y-BOCSc 3 25% NR (NR) 16 (Fair)
Notes. BDI-I/II = Beck Depression Inventory; BPD = borderline personality disorder; BSI = Brief Symptom Inventory; CAT = cognitive analytic therapy; CAT-
NR = CAT without narrative reformulation component; CCAT = Competence in Cognitive Analytic Therapy measure; CORE = Clinical Outcomes in Routine
Evaluation; GHQ = General Health Questionnaire; HADS-D = Hospital Anxiety and Depression Scale-Depression subscale; IIP = Inventory of Interpersonal
Problems; MT = medium-term CAT; N/A = not applicable; N = number of patients; NR = not reported; PBE = practice-based evidence; PD = personality
disorder; PHQ-9 = Patient Health Questionnaire-9; PROQ-2 = Person’s Relating to Others Questionnaire; RCT = randomized controlled trial; RD = reliable
deterioration; SCL-90-R = Symptom Checklist-90-Revised; SOFAS = Social and Occupational Functioning Assessment Scale; ST = short-term CAT.
aInsufficient data to calculate follow-up effect sizes.; bRCT studies included in secondary between-groups quantitative synthesis.; cMeasure not relevant to outcome
classification used in primary pre–post quantitative synthesis.
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Figure 2. Forest plots of pre–post CAT treatment effect sizes (ES) for (a) global functioning, (b)
interpersonal functioning, and (c) depression outcomes [grey error bars represent prediction intervals
for overall aggregate CAT treatment estimates].
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outcomes. Three studies [26–28 in Table 1] were not eligible for inclusion due to
outcomes being assessed with measures that were not relevant to the specific outcome
classifications (i.e., outcomes were assessed with disorder-specific measures; anorexia
nervosa (k = 2) and OCD (k = 1) presentations). The remaining k = 25 studies evaluated
CATbased on outcomes of global functioning, interpersonal problems, and/or depression
symptoms. The Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM)
was the most commonly used measure of global functioning (k = 8), followed by the
Symptom Checklist-90-Revised (SCL-90-R; k = 6). All but k = 2 studies that assessed
interpersonal difficulties used the Inventory of Interpersonal Problems (IIP; k = 9). The
most common depression measure was the Beck Depression Inventory (BDI-I or II;
k = 9).
Effect of CAT on global functioning
Pre–post and follow-up comparisons. Twenty-one comparisons (extracted from 20
studies) totalling N = 628 participants provided pre–post treatment outcomes of global
functioning. Figure 2a presents the pooled effect size (ES), showing large, significant
improvements in global functioning following CAT (ES = 0.86; 95% CI 0.71–1.01; 95% PI
0.24–1.48; Z = 11.87; p < .001). There was significant, moderate between-study hetero-
geneity (I2 = 70%; Q = 67.47, p < .001). End of treatment to follow-up data were
provided in 11 comparisons (N = 146 participants). There was no significant change in
functioning at follow-up, indicating the changes in global functioning were maintained
(ES = 0.12; 95% CI 0.04 to 0.28; 95% PI 0.14 to 0.37; Z = 1.64; p = .100). There was
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Figure 3. Funnel plots for distribution of studies reporting pre–post CAT treatment outcomes for (a)
global symptoms, (b) interpersonal functioning, and (c) depression symptoms [black and grey error bars
represent confidence and prediction intervals, respectively].
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minimal, non-significant between-study heterogeneity detected (I2 = 14%; Q = 11.67,
p = .308).
Publication bias. Visual inspection of the funnel plot in Figure 3a and statistical testing
using Egger’s regression did not indicate substantial asymmetry in study distribution for
reporting of pre–post global functioning outcomes (B = 0.62, t(20) = 0.58, p = .567).
Trim and fill imputation accounted for two smallermissing studieswith aminimal to small
CAT treatment effects, producing a slightly reduced overall pooled treatment estimate
(ES = 0.81; 95% CI 0.65–0.96) that was still representative of a large effect. Taken
together, the analyses suggest minimal impact of reporting bias on the pooled treatment
estimate.
Effect of CAT on interpersonal difficulties
Pre–post and follow-up comparisons. Twelve comparisons (extracted from 11 studies)
totalling N = 492 participants provided pre–post interpersonal change outcomes. The
pooled ES demonstrated moderate-to-large, significant reductions in interpersonal
difficulties (Figure 2c; ES = 0.74, 95% CI 0.54–0.94; 95% PI 0.22–1.25; Z = 8.08;
p < .001). There was significant, moderate between-study heterogeneity (I2 = 64%;
Q = 30.59, p = .001). End of treatment to follow-up data were provided in seven
comparisons (N = 94 participants). There was a small, significant effect in favour of
further reductions in interpersonal difficulties over the follow-up period (ES = 0.38; 95%
CI 0.15–0.61; 95% PI 0.15–0.61; Z = 4.08; p < .001). Between-study heterogeneity was
not detected (I2 = 0%; Q = 5.77, p = .450).
Publication bias. Visual inspection of the pre- to post-treatment funnel plot of
interpersonal difficulty ES (see Figure 3b) suggested some slight asymmetry in the
distribution of studies; however, statistical testing with Egger’s regression did not detect
significant reporting bias (B = 0.28, t(11) = 1.18, p = .265). Trim and Fill imputed data
for one missing smaller study with a small deterioration effect after CAT, resulting in
minimal change in the CAT ES estimate (ES = 0.73, 95% CI 0.53–0.92).
Effect of CAT on depression
Fourteencomparisons (extracted from12studies) totallingN = 586participantsprovided
pre–post treatment data for depression outcomes. The pooled ES demonstrated large,
significant reductions in depression symptoms (Figure 2c; ES = 1.05, 95% CI 0.80–1.29;
95% PI 0.26–1.84; Z = 9.17; p < .001). There was significant, large between-study
heterogeneity (I2 = 80%;Q = 64.56,p < .001).Comparisonsbetweenoutcomesat endof
treatment and follow-upwere available from8comparisons (N = 193participants). There
was minimal change at follow-up indicating depression symptomatology remained stable
(ES = 0.13; 95% CI 0.08 to 0.35; 95% PI 0.28 to 0.55; Z = 1.47; p = .071). Between-
study heterogeneity was low and not significant (I2 = 41%; Q = 11.86, p = .105).
Publication bias. Visual inspection of the pre- to post-treatment funnel plot of
depression ES (see Figure 3c) suggested there was some asymmetry in the distribution of
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studies, indicating larger effects of CAT on depression outcomes were more likely to be
reported by small N studies. Egger’s regression did not detect a statistically significant
influence of reporting bias (B = 0.72, t(13) = 0.60, p = .561). Trim and Fill imputed three
studies with minimal to small CAT treatment effects producing a reduced effect estimate
of 0.88 (95% CI 0.62–1.14) suggesting some impact of reporting bias, albeit still
representing a large effect.
Moderator analyses
Meta-regressions (Table 2) and subgroup analyses (Table 3) investigating moderators of
CAT treatment effects explored the significant between-study heterogeneity identified in
the pre–post treatment comparisons for each outcome. Variations in treatment effects for
global functioning, interpersonal problems, and depression symptoms were not
explained by differences in participant age or gender. Initial analyses suggested smaller
ESs were associated with longer CAT treatment for global functioning and higher study
quality for interpersonal problems; however, after accounting for multiple testing both
effects were no longer significant at the Bonferroni-adjusted p-value (< .0125). Analysis of
ESs for categorical subgroups foundno significant differences based on thepresenceof PD
cases versus other presentations, or whether the study was practice-based or an RCT.
Effects for global functioning and depression symptoms were not associated with
variations in ESs for different formats of CAT, orwhen therapywas delivered by a qualified
CAT therapist. However, larger ESs for interpersonal difficulties were associated with
individual treatment delivered by CAT qualified therapists, explaining 53% and 20% of the
observed variance, respectively (although after adjustment, the effect of therapist
qualification fell just short of the Bonferroni-corrected significance threshold). Moderate-
to-large heterogeneity was still present in over half the subgroups.
Sensitivity analyses
Sensitivity analyses explored the impact of imputed pre–post correlation values (r) on
overall CAT treatment estimates and are presented in Table 4. For each outcome, the
magnitude of the CAT treatment effect with different r imputations ranged between
moderate and large effects in favour of a significant improvement following CAT. This
suggests imputation of missing values had a minimal to low impact on the overall
conclusions that could be drawn. Depression outcome had a wider range of potential
effect magnitude (0.60–1.30), than global functioning (0.72–0.97) and interpersonal
difficulties (0.57–0.87), thus indicating interpretations may be slightly less reliable for
depression outcomes. In addition, eight studies reported r for global functioning scores
enabling a comparison of pooled treatment estimates using the true value or an imputed
value (0.6) of r. The pooled treatment estimate was 0.94 (95% CI 0.54–.1.33; Z = 5.65;
p < .001) when using an imputed estimate of r (0.6) and 0.98 (95% CI 0.65–.1.30;
Z = 7.05; p < .001) when using the true study value of r.
Secondary meta-analysis of RCT between-groups treatment effects
Meta-analytic comparisons were conducted to aggregate the effect of CAT compared to a
comparator condition in RCTs at post-treatment, and where available, at follow-up. One
RCT could not be included as CAT was compared to a dismantled version of CAT [19]. In
the remaining nine RCTs, CAT was compared to another intervention in k = 3 studies,
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Table 2. Meta-regression analyses of pre–post CAT treatment outcomes
Outcome Variable k B-coefficient 95% CI SE p R2 (%)
Global functioning Quality (rating 0–28) 21 0.01 0.06 to 0.04 0.02 .666 1.22
Gender (% of males) 19 0.00 0.01 to 0.00 0.00 .294 7.90
Mean age (16 – 49 years) 16 0.01 0.01 to 0.04 0.01 .191 11.24
Treatment duration (5–30 sessions) 20 0.03 0.06 to 0.00 0.01 .029* 21.78
Interpersonal functioning Quality (rating 0–28) 12 0.06 0.11 to 0.01 0.02 .015* 36.71
Gender (% of males) 12 0.00 0.01 to 0.01 0.00 .586 2.51
Mean age (31–49 years) 9 0.02 0.03 to 0.07 0.02 .271 10.74
Treatment duration (16–24 sessions) 12 0.01 0.04 to 0.06 0.02 .572 2.80
Depression Quality (rating 0–28) 14 0.03 0.03 to 0.08 0.03 .314 8.48
Gender (% of males) 13 0.00 0.01 to 0.01 0.01 .656 1.69
Mean age (27–49 years) 10 0.02 0.03 to 0.06 0.02 .475 5.31
Treatment duration (8–24 sessions) 12 0.02 0.07 to 0.03 0.02 .411 7.48
Note. CI = confidence interval; k = number of comparisons; R2 = percentage of variation explained; SE = standard error.
*Significant at p < .05 threshold.; **Significant at Bonferroni-adjusted p < .0125 threshold for multiple testing. Positive effect size indicates in favour of pre–post
improvement.
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Table 3. Subgroup analysis of pre–post CAT treatment effect outcomes
Outcome Variable Subgroup k ES (g) 95% CI I2 (%) p (between subgroups) R2 (%)
Global functioning Study type PBE 17 0.87* 0.70 to 1.04 75* .641 0.32
RCT 4 0.80* 0.55 to 1.05 23
Therapist CAT qualified Qualified 15 0.90* 0.73 to 1.06 57* .500 0.67
Not qualified 6 0.78* 0.49 to 1.07 84*
Format 1:1 20 0.89* 0.76 to 1.03 54* – –
Group 1 0.37* – –
Diagnosis Include PD cases 6 0.81* 0.70 to 0.91 0 .531 0.58
Other diagnoses 15 0.88* 0.68 to 1.07 79*
Interpersonal functioning Study type PBE 9 0.80* 0.61 to 0.98 68* .118 8.01
RCT 3 0.48* 0.12 to 0.84 50
Therapist CAT qualified Qualified 6 0.94* 0.74 to 1.14 22 .015* 19.81
Not qualified 5 0.59* 0.39 to 0.79 69*
Format 1:1 10 0.79* 0.67 to 0.90 24 <.001** 52.71
Group 2 0.36* 0.19 to 0.54 2
Diagnosis Include PD cases 4 0.76* 0.24 to 1.28 75* .892 0.06
Other diagnoses 8 0.72* 0.55 to 0.89 61*
Depression Study type PBE 10 1.03* 0.76 to 1.30 78* .864 0.05
RCT 4 1.08* 0.60 to 1.56 83*
Therapist CAT qualified Qualified 7 1.22* 0.89 to 1.56 59* .259 1.98
Not qualified 6 0.95* 0.59 to 1.30 87*
Format 1:1 13 1.11* 0.89 to 1.32 70* – –
Group 1 0.49* – –
Diagnosis Include PD cases 1 0.85* – – – –
Other diagnoses 13 1.07* 0.82 to 1.31 81*
Notes. CI = confidence interval; ES = effect size; k = number of comparisons; PBE = practice-based evidence; PD = personality disorder; R2 = percentage of
variation explained; RCT = randomized controlled trial.
*Significant at p < .05 threshold.; **Significant at Bonferroni-adjusted p < .0125 threshold for multiple testing of between subgroups. Positive effect size indicates in
favour of pre–post improvement.
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Table 4. Sensitivity analysis of imputed pre–post correlations (r) on aggregated CAT treatment effect
Outcome k
Main analysis estimates
Imputed value of r
0.6 0.0 0.25 0.5 0.75
Global functioning 21 0.86 (0.71–1.01) 0.72 (0.53–0.92) 0.75 (0.58–0.93) 0.81 (0.66–0.97) 0.97 (0.81–1.13)
Interpersonal functioning 11 0.74 (0.54–0.94) 0.57 (0.35–0.79) 0.61 (0.41–0.81) 0.68 (0.49–0.88) 0.87 (0.62–1.12)
Depression 14 1.05 (0.80–1.29) 0.66 (0.49–0.83) 0.77 (0.58–0.96) 0.94 (0.72–1.17) 1.30 (0.99–1.61)
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treatment as usual (TAU) in k = 5 studies, and no treatment in k = 1 study (see
supplementary materials for between-group comparator characteristics). Outcomes
assessed were disorder-specific outcomes (k = 3 [Anorexia Nervosa k = 2; OCD k = 1]),
interpersonal problems (k = 2), global functioning (k = 1), or a combination of global
functioning, interpersonal problems, and/or depression outcomes (k = 3). Dropout rates
for CATduring clinical trials ranged between0 and 38% (mean = 23%) compared to 6-44%
(mean = 26%) for comparators.
Post-treatment and follow-up comparisons
Nine RCT comparisons totalling N = 352 participants evaluated post-treatment CAT
outcomes compared to a control condition (CAT N = 181; control N = 171). The pooled
(a)
(b)
Figure 4. Forest plots of between-group effect sizes (ES) from randomized controlled trial (RCT)
outcomes of CAT versus a comparator condition at (a) post-treatment and (b) follow-up [grey error bars
represent prediction intervals for overall aggregate estimates].
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ES presented in Figure 4 indicates a small, significant treatment effect in favour of CAT
(ES = 0.36, 95% CI 0.00–0.72; 95% PI- 0.48–1.19; Z = 2.25; p = .024). There was
significant, moderate between-study heterogeneity (I2 = 62%; Q = 20.85, p = .008). The
pooled ES including only the six comparisons of post-treatment CAT outcomes versus
TAU/no treatment conditions showed amoderate effect in favour of CAT (ES = 0.53, 95%
CI 0.01–1.05, 95% PI0.49 to 1.55, Z = 2.63, p = .009, I2 = 64%, Q = 13.99, p = .016).
Six follow-up treatment arm comparisons provided follow-up data on outcomes for CAT
versus any control conditions for N = 175 participants (CAT N = 88; control N = 87).
The pooled ES demonstrated there was no difference in follow-up outcomes (Figure 4;
ES = 0.00, 95% CI 0.26 to 0.26; 95% PI- 0.27–0.28; Z = 0.03; p = .975). Between-study
heterogeneity was not detected (I2 = 1%; Q = 5.07, p = .408). The pooled follow-up ES
for the four TAU/no treatment comparisons only was ES = 0.06 (95% CI 0.56 to 0.68;
95% PI- 0.88 to 1.00; Z = 0.31; p = .758, I2 = 40%, Q = 5.00, p = .172).
Discussion
CAT is defined through its relational and collaborative approach, inworkingwith the past,
using enactments within the therapeutic relationship and associated analysis of habitual
relationship patterns, via analysis of reciprocal role dynamics and intra- and interpersonal
procedures (Ryle & Kellett, 2018). The present study has built on previous reviews of the
effectiveness of CAT (Calvert &Kellett, 2014; Ryle et al., 2014) to provide a contemporary
quantitative synthesis of the state of the CAT treatment outcome evidence base. This was
achieved by specifying CAT pre–post treatment effects for global functioning, interper-
sonal difficulties, and depression, and also quantifying the longer-term effects of CAT for
the first time. The uncontrolled ES found was comparable to the pre–post ES found in the
previous quantitative review (d = 0.83; Ryle et al., 2014). Moderators of CAT treatment
effects were explored, alongside consideration of the impact of largely PBE studies on the
confidence in overall treatment estimates. An aggregated controlled CAT effect size has
also been estimated to provide a preliminary indication of CAT effectiveness, in the
context of the acknowledged limitations of uncontrolled pre–post treatment effects. CAT
continues to be used to treat a variety of typically severe and complex psychological
disorders; 12 separate diagnoses were present in the current review with evaluations of
CAT for disorders including psychosis, morbid jealousy, and chronic pain recently
completed. However, less than 25% of studies assessed adverse event rates during CAT,
and so, this needs to become a more widely assessed safety outcome.
The findings overall show patients who undergo CAT experience improvements
across a range of clinical difficulties, seeing moderate-to-large pre–post reductions in
global symptoms (g = 0.86), interpersonal difficulties (g = 0.74), and depression
(g = 1.05) and small–moderate beneficial effects compared to comparators (g = 0.36–
0.53). Although the pre–post improvements cannot be specifically attributed to CAT, the
superior between-groups outcomes suggest CAT is effective. Evidence of outcome
reductions was maintained at medium-/long-term follow-up in functioning and depres-
sion, and it is noteworthy that interpersonal difficulties significantly reduced over follow-
up time. Dropout was low (15%) suggesting that CAT is an acceptable to patients.
Overall, 28 CAT treatment studies were synthesized, with 25 studies included in a
synthesis of pre–post outcomes and nine studies in a RCT between-groups synthesis. This
encompassed an additionalN = 12 studies (including four RCTs) that had been published
since the CAT reviews in 2014 called for urgent development of the evidence base, and in
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particular the conduct of RCTs. The increase in the number of RCTs (i.e., 36% of studies
were RCTs) indicates that the CAT evidence base is developing. However, there is still a
tendency towards favouring PBE-style evaluations typically in complex clinical popula-
tions. It is encouraging that CAT has developed translations of themodel in terms of group
delivery (Calvert, Kellett, & Hagan, 2015), a consultancy version for patients in secondary
care that community teams struggle to engage (Kellett et al., 2019c), an 8-session version
suitable for step 3delivery in ImprovingAccess to Psychological Therapies (IAPT) services
(Kellett et al., 2018), forensic CAT (Kellett et al., 2019d), and a psychoeducational version
for step 2 delivery in IAPT services (Meadows & Kellett, 2017).
Assessment of the specific impact of CAT on interpersonal difficulties was particularly
indicated, as CAT presents itself as a relationally informed psychotherapy, capable of
conceptualizing and changing interpersonal processes (Ryle & Kellett, 2018). In terms of
pre–post change, then large improvements in global functioning and depression and a
moderate improvement in interpersonal difficulties were observed following CAT.
However, the follow-up meta-analysis revealed little further change in functioning and
depression (i.e., neither significant improvements nor deterioration indicating that
treatment gains were maintained), but with significant improvements in interpersonal
distress occurring over the follow-up period. This suggests that the relational nature of
CAT (Ryle&Kellett, 2018) is impacting on interpersonal dynamics usefully over time. The
results concerning interpersonal change therefore provide support for the underlying
theory and approach of CAT.
The high presence of heterogeneity between studies warranted exploration through
meta-regression and subgroup analyses; however, limited moderators of CAT treatment
effect were identified. While it is important to remember moderator analysis cannot be
used to infer causality, it provides insight into potential treatment effects (Cochrane
Collaboration, 2011ollaboration, 2011). ESs across all outcomes did not differ according to
participant age, gender, diagnosis, or for the outcomes in RCT versus PBE studies.
However, it is likely these analyses were hampered by small sample sizes and the limited
number of studies within subgroup analyses creating a lack of power to detect small
effects (Cochrane Collaboration, 2011ollaboration, 2011). All outcomes showed a trend
of larger effects for individually delivered CAT compared to group formats; however, only
interpersonal outcomes had multiple studies of group CAT to enable subgroup
comparisons. One-to-one CAT produced larger effects, whereas group CAT outcomes
were significantly more modest. This may be a reflection of the relative lack of theoretical
work concerning group delivery of the model, as only two group CAT studies were
available and were in complex patient groups (trauma/forensic) that could be confound-
ing the effect. Smaller global functioning effects were associated with longer treatment
contracts, which is possibly an artefact of more complex clinical presentations being
offered the 24-session version of the model in routine services (Marriott & Kellett, 2009).
Limitations
The findings need to be considered alongside methodological limitations. Many of the
limitations of the current review reflect the limitations of the evidence base, rather than
the methods used in this study. CAT is clearly frequently used in the treatment of highly
varied patient groups, and this limited the specificity of the review, particularly through
the lack of bodies of disorder-specific CAT outcome research. CAT has generated most
evidence around the treatment of borderline personality disorder. Restricting the search
to peer-reviewed studies may have overlooked eligible studies in the grey literature. The
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review would have been improved through more consistent efforts to access the grey
literature.The review was limited by the wide variety of measures used in the CAT
outcome literature, so the creation of outcome classification clusters could be challenged
andmay have introduced bias (Puhan, Soesilo, Guyatt, & Sch€unemann, 2006). Therewas a
lack of studies comparing CAT to active treatments, and so, the results cannot be used to
comment reliably on the comparative efficacy of CAT (Bucher, Guyatt, Griffith, &Walter,
1997).
The number of included studies within outcomes and within-study sample sizes was
small, which can inflate ESs and provide inaccurate evaluations of between-study
heterogeneity (Inthout, Ioannidis, Borm, & Goeman, 2015). In addition, subsequent
moderator analyses were subject to low power and insufficient subgroups to be able to
reliably detect variation in effects (Guolo & Varin, 2017). For example, the number of
studies of adults within specific diagnoses was low, especially when compared to similar
meta-analyses for other treatment modalities (Tolin et al., 2015). The methodological
quality of included studies was generally sub-optimal, and there were indications that for
some outcomes, lower quality studies might have produced larger effects. Poor study
quality is commonly criticized for contributing inflated ESs (Altman, 1994). The lack of
studies employing the CCAT (i.e., 16%) means that the certainty with which CAT was
actually being delivered is questionable. Assessing dropout by calculating an average is
problematic as precision and variance in study estimates is not accounted for. The amount
of studies assessing serious adverse events was low (23%).
Finally, the type of the evidence available means that ESs may have been susceptible
to uncontrolled error thus biasing their interpretation. As the CAT evidence base has a
strong reliance on PBE, pre–post rather than between-group ESs were used in the
primary analysis. Critics argue such uncontrolled ESs should be avoided in meta-analyses,
as they may index change caused by external factors (Cuijpers, Weitz, Cristea, & Twisk,
2017). To control for violation of independence in pre–post ESs alongside limited
reporting of the correlation of pre–post scores, a fixed correlation value was used when
data were missing. However, when this fixed value is considerably different from the
true correlation, it has been shown to inflate ES estimates (Cuijpers et al., 2017). While
attempts were made to manage these biases through the use of Hedges g correction for
small sample sizes, accounting for pre–post correlation and assessing the impact of
different imputed values, it does raise questions as to whether these samples were
suitable to be combined.
Research, clinical, and organizational implications
Researchers still need to strive to generate evidence, particularly using randomized and
controlled methods, and produce CAT evidence for specific diagnoses. CAT needs to
generate more evidence for its acceptability and effectiveness with common mental
health problems. The evidence base comprises mostly of one-to-one CAT delivery, and
more evaluations of group CAT are indicated. It is essential that CAT outcome studies
consistently report adverse event rates. Competency assessment should be the norm
rather than the exception in PBE- and EBP-style studies. Evaluation of CAT is hampered by
a lack of consensus on types of outcome used to evaluate treatment, largely it appears due
to the complexity and variety of disorders treated. Use of a generic measure of
symptomatic/functioning, such as CORE-OM (Barkham, Gilbert, Connell, Marshall, &
Twigg, 2005),would enablemore robust andwidespreadcomparisons across studies. The
more frequent use of the Personality Structure Questionnaire (PSQ; Pollock, Broadbent,
22 Craig Hallam et al.
Clarke, Dorrian, & Ryle, 2001) is also indicated as this is based on the CAT model and has
recently been cross-culturally validated (Berrios, Kellett, Fiorani, & Poggioli, 2016).
Given the frequency of PBE-style CAT studies, it would be useful for future pre–post
studies to report correlations between pre–post scores as standard. Short- and long-term
follow-up needs to be routinely built into the design of any future CAT PBE or EBP studies
to clarify the true durability of CAT treatment effects. Although the current study provides
a basic commentary on dropout rates as a proxy for treatment acceptability, the evidence
base would benefit from a meta-analysis of dropout from routine service delivery and
clinical trials of CAT (see Imel, Laska, Jakupcak, & Simpson, 2013 for an example). Future
studies need to enable increased patient choice, and so, completion of patient preference
trials is indicated and is underway (Kellett et al., 2019a). The present meta-analysis was
based on nomothetic psychometric outcomes. However, as change in ideographic ‘target
problems’ specific to the patient is at the core of evaluating change in the model (Ryle &
Kerr, 2002), a meta-analysis of the large CAT single-case experiential design literature is
also indicated.
Both CAT accredited therapists and therapists without CAT accreditation produced
statistically similarly large treatment effects for symptomatic and functioning changes.
However, reductions in interpersonal difficulties when CAT was delivered by unaccred-
ited therapistsweremoderate andwere significantly lower than the large effects observed
for accredited CAT therapists (albeit just short of significance after adjusting for multiple
testing). Given that the implementation of methods to help patients change their
interpersonal roles and procedures is thought to play a crucial role in the benefits
experienced (Ryle &Kellett, 2018), this implies that the interpersonal work of CAT needs
to be supported through formal training and associated clinical supervision.
Conclusions
The aims of the study were met, and a contemporary and methodologically improved
meta-analysis of the CAT evidence base was produced. The findings add to a growing
body of evidence suggesting relationally informed therapies can be beneficial in
reducing psychological distress and interpersonal difficulties (Fonagy, 2015; Jakobsen,
Hansen, Simonsen, & Gluud, 2011). The results of this review highlight an emerging,
but still relatively small diagnostically specific CAT evidence base. Despite method-
ological limitations, the within-groups and preliminary between-groups findings taken
together suggest CAT is useful across a range of clinical presentations. Patients
particularly appear to benefit interpersonally, and the findings reported here do
support the commissioning of CAT for disorders with a significant interpersonal
element. In conclusion, these findings should provide sufficient impetus for a
coordinated research strategy to move the CAT evidence base forward in a targeted
and productive manner.
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